Shortening of the ventricular fibrillatory intervals after administration of verapamil in a patient with Brugada syndrome and vasospastic angina

被引:12
作者
Chinushi, Masaomi [1 ]
Tagawa, Minoru
Nakamura, Yuichi
Aizawa, Yoshifusa
机构
[1] Niigata Univ, Sch Med, Sch Hlth Sci, Niigata 9518518, Japan
[2] Niigata Univ, Sch Med, Dept Internal Med 1, Niigata 9518518, Japan
[3] Nagaoka Chuou Hosp, Dept Cardiol, Nagaoka, Niigata 9408653, Japan
关键词
Brugada syndrome; vasospastic angina; calcium antagonism; verapamil;
D O I
10.1016/j.jelectrocard.2005.10.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 43-year-old man presented with electrocardiographic findings consistent with Brugada syndrome. Though the baseline coronary angiogram was normal, intracoronary infusion of ergonovine maleate caused complete occlusion of the left anterior descending and a 99% occlusion of the proximal right coronary artery, each relieved by intracoronary isosorbide dinitrate. Double extrastimuli delivered at the right ventricular outflow tract induced ventricular fibrillation terminated by a 200-J shock. Verapamil, 10 mg IV, increased ST-segment elevation and programmed stimulation repeated after the drug induced ventricular fibrillation with shorter F-F intervals and lower amplitude signals, which was not terminated by 200 J and required an additional 360-J shock. Ca2+ antagonism may have been adverse in this patient with Brugada syndrome because the drug has the potential to increase the voltage gradient through the right ventricle and to slow intraventricular conduction at very fast heart rates. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:331 / 335
页数:5
相关论文
共 9 条
[1]   Brugada syndrome - Report of the second consensus conference - Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association [J].
Antzelevitch, C ;
Brugada, P ;
Borggrefe, M ;
Brugada, J ;
Brugada, R ;
Corrado, D ;
Gussak, I ;
LeMarec, H ;
Nademanee, K ;
Riera, ARP ;
Shimizu, W ;
Schulze-Bahr, E ;
Tan, H ;
Wilde, A .
CIRCULATION, 2005, 111 (05) :659-670
[2]   Class I antiarrhythmic drug and coronary vasospasm-induced T wave alternans and ventricular tachyarrhythmia in a patient with Brugada syndrome and vasospastic angina [J].
Chinushi, Y ;
Chinushi, M ;
Toida, T ;
Aizawa, Y .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2002, 13 (02) :191-194
[3]   Role of sodium and calcium channel block in unmasking the Brugada syndrome [J].
Fish, JM ;
Antzelevitch, C .
HEART RHYTHM, 2004, 1 (02) :210-217
[4]   A case of vasospastic angina presenting Brugada-type ECG abnormalities [J].
Itoh, E ;
Suzuki, K ;
Tanabe, Y .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1999, 63 (06) :493-495
[5]   MECHANISM OF CALCIUM-CHANNEL BLOCKADE BY VERAPAMIL, D600, DILTIAZEM AND NITRENDIPINE IN SINGLE DIALYZED HEART-CELLS [J].
LEE, KS ;
TSIEN, RW .
NATURE, 1983, 302 (5911) :790-794
[6]   ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome [J].
Noda, T ;
Shimizu, W ;
Taguchi, A ;
Satomi, K ;
Suyama, K ;
Kurita, T ;
Aihara, N ;
Kamakura, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (10) :1841-1847
[7]   A mechanism of transition from ventricular fibrillation to tachycardia - Effect of calcium channel blockade on the dynamics of rotating waves [J].
Samie, FH ;
Mandapati, R ;
Gray, RA ;
Watanabe, Y ;
Zuur, C ;
Beaumont, J ;
Jalife, J .
CIRCULATION RESEARCH, 2000, 86 (06) :684-691
[8]   Unsuccessful internal defibrillation in Brugada syndrome: Focus on refractoriness and ventricular fibrillation cycle length [J].
Watanabe, H ;
Chinushi, M ;
Sugiura, H ;
Washizuka, T ;
Komura, S ;
Hosaka, Y ;
Furushima, H ;
Watanabe, H ;
Hayashi, J ;
Aizawa, Y .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2005, 16 (03) :262-266
[9]   Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation [J].
Yan, GX ;
Antzelevitch, C .
CIRCULATION, 1999, 100 (15) :1660-1666